ReviewPostepy dermatologii i alergologii2026
Latex allergy and medical aspects of the use of latex products.
Review in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Latex allergy remains a significant occupational and clinical challenge in healthcare environments. Aim: The aim of this review study was to systematically analyse existing scientific data on the allergenic potential of latex, the clinical typology of allergic reactions, diagnostic capabilities, and preventive strategies in the medical environment. Methods: The review included systematic reviews, clinical and epidemiological studies as well as case reports. All publications appeared in peer-reviewed journals between 2013 and 2025. Results: The analysis showed that latex allergy is predominantly immunoglobulin E-mediated hypersensitivity to latex proteins ( Conclusions: The results confirm the need for a comprehensive strategy for the prevention of latex allergy in healthcare settings, with an emphasis on protecting staff health, reducing allergen exposure, and ensuring patient safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.